(Q42971229)

12 November 2017

title

Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats (English)

1 reference

12 November 2017

0 references

Maria A Cavasin

1

1 reference

12 November 2017

Hillary Semus

2

1 reference

12 November 2017

Kelly Pitts

3

1 reference

12 November 2017

Yanyu Peng

4

1 reference

12 November 2017

Jennifer Sandoval

5

1 reference

12 November 2017

Joseph Chapo

6

1 reference

12 November 2017

Craig F Plato

7

1 reference

12 November 2017

publication date

1 June 2010

1 reference

Canadian Journal of Physiology and Pharmacology

12 November 2017

published in

1 reference

12 November 2017

volume

88

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

636-643

1 reference

Role of endothelin in systemic and portal resistance in cirrhosis

12 November 2017

cites work

1 reference

Functional significance of endothelin B receptors in mediating sinusoidal and extrasinusoidal effects of endothelins in the intact rat liver.

21 January 2018

1 reference

Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: role in splanchnic hemodynamics

21 January 2018

1 reference

Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats

21 January 2018

1 reference

Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease

21 January 2018

1 reference

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

21 January 2018

1 reference

Mechanisms responsible for the altered pharmacokinetics of bosentan: analysis utilizing rats with bile duct ligation-induced liver dysfunction.

21 January 2018

1 reference

Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

21 January 2018

1 reference

Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension.

21 January 2018

1 reference

Endothelins in the normal and diseased kidney

21 January 2018

1 reference

Portal hypertension: from pathophysiology to clinical practice

21 January 2018

1 reference

Hepatic stellate cells and intrahepatic modulation of portal pressure

21 January 2018

1 reference

Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway

21 January 2018

1 reference

The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver

21 January 2018

1 reference

Activation of rat hepatic stellate cells in culture is associated with increased sensitivity to endothelin 1.

21 January 2018

1 reference

Characterization of endothelin receptors mediating rat hepatic stellate cell contraction

21 January 2018

1 reference

Activation of the hepatic endothelin-system in rats with biliary liver fibrosis.

21 January 2018

1 reference

Regulation of the hepatic endothelin system in advanced biliary fibrosis in rats.

21 January 2018

1 reference

Reduction in hepatic endothelin-1 clearance in cirrhosis

21 January 2018

1 reference

An endothelin A receptor antagonist induces dilatation of sinusoidal endothelial fenestrae: implications for endothelin-1 in hepatic microcirculation

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects.

21 January 2018

1 reference

Hemodynamic effects of Bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/Y10-038

1 reference

12 November 2017

1 reference